CoChat
Sign Up
Cited by 24Obsessive-Compulsive Spectrum DisordersDigital Mental Health InterventionsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Obsessive–compulsive disorder—contamination fears, features, and treatment: novel smartphone therapies in light of global mental health and pandemics (COVID-19)

Open access
Jalal, Baland, Chamberlain, Samuel R., Robbins, Trevor W., Sahakian, Barbara J.·2022·CNS Spectrums
DOI 10.1017/s1092852920001947PMC PMC7691644
Open this paper in CoChat — free accountOpen PDF

Abstract

This review aims to shed light on the symptoms of obsessive–compulsive disorder (OCD) with a focus on contamination fears. In addition, we will briefly review the current therapies for OCD and detail what their limitations are. A key focus will be on discussing how smartphone solutions may provide approaches to novel treatments, especially when considering global mental health and the challenges imposed by rural environments and limited resources; as well as restrictions imposed by world-wide pandemics such as COVID-19. In brief, research that questions this review will seek to address include: (1) What are the symptoms of contamination-related OCD? (2) How effective are current OCD therapies and what are their limitations? (3) How can novel technologies help mitigate challenges imposed by global mental health and pandemics/COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1092852920001947

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anteromedial subthalamic nucleus DBS in OCD is linked with improved cognitive flexibility.

    “As noted, anteromedial subthalamic nucleus DBS in OCD was previously shown to be linked with improved cognitive flexibility (as discussed in a recent review, smartphone interventions may be highly suited for this unmet need; for details, see Jalal et al., 2020).”

    From Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction (2023) · cites this paper as Jalal et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 85

  1. [1]Maruff P, Purcell R, Pantelis C. Obsessive-compulsive disorder In: Harrison JE, Owen AM, eds. Cognitive Deficits in Brain Disorders. London, UK: Taylor and Francis group; 2002: 249– 272.
  2. [2]Robins LN, Helzer JE, Weissman MM, et al Lifetime prevalence of specific psychiatric disorders in three sites. Arc Gen Psychia. 1984; 41(10): 949– 958. doi: 10.1001/archpsyc.1984.01790210031005. 6332590 · DOI · Paper page
  3. [4]Eaton WW, Martins SS, Nestadt G, Bienvenu OJ, Clarke D, Alexandre P. The burden of mental disorders. Epidemiolog Rev. 2008; 30(1): 1– 14. doi: 10.1093/epirev/mxn011. PMC2683377 18806255 · DOI
  4. [6]Fineberg NA, Haddad PM, Carpenter L, et al. The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol. 2013; 27(9): 761– 770. doi: 10.1177/0269881113495118. 23884863 PMC3778981 · DOI
  5. [7]Sahakian BJ. What do experts think we should do to achieve brain health. Neurosci Biobehav Rev. 2014; 43: 240– 258. doi: 10.1016/j.neubiorev.2014.04.002. 24742821 · DOI
  6. [9]Hollander E, Doernberg E, Shavitt R, et al. The cost and impact of compulsivity: a research perspective. Eur Neuropsychopharmacol. 2016; 26(5): 800– 809. doi: 10.1016/j.euroneuro.2016.02.006. 27235690 · DOI
  7. [11]Rachman S. Fear of contamination. Behav Res Ther. 2004; 42(11): 1227– 1255. doi: 10.1016/j.brat.2003.10.009. 15381436 · DOI
  8. [12]Jalal B, McNally RJ, Elias J, Potluri S, Ramachandran VS. Contaminating rubber hands (“multisensory stimulation therapy”) to treat obsessive-compulsive disorder. Front Human Neurosci. 2020; 13: 414. doi: 10.3389/fnhum.2019.00414. PMC6962184 31998095 · DOI
  9. [13]Cyr NR. Obsessive compulsive disorder. AORN J. 2007; 86(2): 277– 280. doi: 10.1016/j.aorn.2007.07.016. 17683725 · DOI
  10. [14]Stein DJ. Obsessive-compulsive disorder and global mental health. Indian J Psychia. 2019; 61: S4– S8. doi: 10.4103/psychiatry.IndianJPsychiatry_515_18. PMC6343414 30745672 · DOI
  11. [15]Olatunji BO, Sawchuk CN, Lohr JM, de Jong PJ. Disgust domains in the prediction of contamination fear. Behav Res Ther. 2004; 42(1): 93– 104. doi: 10.1016/S0005-7967(03)00102-5. 14744526 · DOI
  12. [16]Sawchuk CN, Lohr JM, Tolin DF, Lee TC, Kleinknecht RA. Disgust sensitivity and contamination fears in spider and blood-injection-injury phobias. Behav Res Ther. 2000; 38(8): 753– 762. doi: 10.1016/S0005-7967(99)00093-5. 10937424 · DOI
  13. [17]Olatunji BO, Sawchuk CN, Arrindell WA, Lohr JM. Disgust sensitivity as a mediator of the sex differences in contamination fears. Personality Individ Diff. 2005; 38(3): 713– 722. doi: 10.1016/j.paid.2004.05.025. · DOI
  14. [18]Olatunji BO, Williams NL, Lohr JM, Sawchuk CN. The structure of disgust: domain specificity in relation to contamination ideation and excessive washing. Behav Res Ther. 2005; 43(8): 1069– 1086. doi: 10.1016/j.brat.2004.08.002. 15967177 · DOI
  15. [19]Cisler JM, Olatunji BO. Components of attentional biases in contamination fear: evidence for difficulty in disengagement. Behav Res Ther. 2010; 48(1): 74– 78. doi: 10.1016/j.brat.2009.09.003. 19781691 PMC2812617 · DOI
  16. [20]Charash M, McKay D. Attention bias for disgust. J Anx Disord. 2002; 16(5): 529– 541. doi: 10.1016/S0887-6185(02)00171-8. 12396210 · DOI
  17. [21]Husted DS, Shapira NA, Goodman WK. The neurocircuitry of obsessive-compulsive disorder and disgust. Progr Neuro-Psychopharmacol Biol Psychia. 2006; 30(3): 389– 399. doi: 10.1016/j.pnpbp.2005.11.024. 16443315 · DOI
  18. [22]Knowles KA, Jessup SC, Olatunji BO. Disgust in anxiety and obsessive-compulsive disorders: recent findings and future directions. Current Psychia Rep. 2018; 20(9): 68. doi: 10.1007/s11920-018-0936-5. PMC6422162 30094516 · DOI
  19. [24]Berlin HA, Stern ER, Ng J, et al. Altered olfactory processing and increased insula activity in patients with obsessive–compulsive disorder: an fMRI study. Psychia Res: Neuroimag. 2017; 262(217): 15– 24. doi: 10.1016/j.pscychresns.2017.01.012. PMC5373557 28208068 · DOI
  20. [25]Shapira NA, Liu Y, He AG, et al. Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychia. 2003; 54(7): 751– 756. doi: 10.1016/S0006-3223(03)00003-9. 14512216 · DOI
  21. [26]Stein DJ, Arya M, Pietrini P, Rapoport JL, Swedo SE. Neurocircuitry of disgust and anxiety in obsessive-compulsive disorder: a positron emission tomography study. Metabolic Brain Dis. 2006; 21(2–3): 255– 265. doi: 10.1007/s11011-006-9021-6. 16850255 · DOI · Paper page
  22. [27]Lawrence NS, An SK, Mataix-Cols D, Ruths F, Speckens A, Phillips ML. Neural responses to facial expressions of disgust but not fear are modulated by washing symptoms in OCD. Biol Psychia. 2007; 61(9): 1072– 1080. doi: 10.1016/j.biopsych.2006.06.033. 17097073 · DOI
  23. [28]Bhikram T, Abi-Jaoude E, Sandor P. OCD: obsessive-compulsive … disgust? The role of disgust in obsessive–compulsive disorder. J Psychia Neurosci. 2017; 42(5): 300– 306. doi: 10.1503/jpn.160079. PMC5573572 28375077 · DOI
  24. [29]Tolin DF, Worhunsky P, Maltby N. Sympathetic magic in contamination-related OCD. J Behav Ther Exp Psychia. 2004; 35(2): 193– 205. doi: 10.1016/j.jbtep.2004.04.009. 15210379 · DOI
  25. [30]Riskind JH, Abreu K, Strauss M, Holt R. Looming vulnerability to spreading contamination in subclinical OCD. Behav Res Ther. 1997; 35(5): 405– 414. doi: 10.1016/S0005-7967(96)00113-1. 9149449 · DOI
  26. [31]Rozin P, Millman L, Nemeroff C. Operation of the laws of sympathetic magic in disgust and other domains. J Personality Soc Psychol. 1986; 50(4): 703– 712. doi: 10.1037/0022-3514.50.4.703. · DOI
  27. [32]Jalal B, McNally RJ, Elias J, Ramachandran VS. “Vicarious exposure”— “spooky action” at a distance in obsessive-compulsive disorder. In review.
  28. [33]McKay D. Treating disgust reactions in contamination-based obsessive-compulsive disorder. J Behav Ther Exp Psychia. 2006; 37(1): 53– 59. doi: 10.1016/j.jbtep.2005.09.005. 16253206 · DOI · Paper page
  29. [34]Athey AJ, Elias JA, Crosby JM, et al. Reduced disgust propensity is associated with improvement in contamination/washing symptoms in obsessive–compulsive disorder. J Obsessive–Compulsive Rel Disord. 2015; 4: 20– 24. doi: 10.1016/j.jocrd.2014.11.001. PMC4254727 25485229 · DOI
  30. [35]Lochner C, Simmons C, Kidd M, et al. Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder. Behav Brain Res. 2012; 226(1): 274– 280. doi: 10.1016/j.bbr.2011.09.029. 21963422 · DOI
  31. [36]Fradkin I, Adams RA, Parr T, Roiser JP, Huppert JD. Searching for an anchor in an unpredictable world: a computational model of obsessive compulsive disorder. Psychol Rev. 2020; 127(5), 672– 699. 32105115
  32. [37]Szechtman H, Woody E. Obsessive–compulsive disorder as a disturbance of security motivation. Psychol Rev. 2004; 111(1): 111– 127. doi: 10.1037/0033-295X.111.1.111. 14756589 · DOI
  33. [40]Teufel C, Fletcher PC. Forms of prediction in the nervous system. Nature Rev Neurosci. 2020; 21: 231– 242. doi: 10.1038/s41583-020-0275-5. 32221470 · DOI · Paper page
  34. [42]Tallis F. Compulsive washing in the absence of phobic and illness anxiety. Behav Res Ther. 1996; 34(4): 361– 362. doi: 10.1016/0005-7967(95)00079-8. 8871369 · DOI
  35. [43]Gillan CM, Morein-Zamir S, Urcelay GP, et al. Enhanced avoidance habits in obsessive–compulsive disorder. Biol Psychia. 2014; 75(8): 631– 638. doi: 10.1016/j.biopsych.2013.02.002. PMC3988923 23510580 · DOI · Paper page
  36. [45]Fineberg NA, Apergis-Schoute AM, Vaghi MM, et al. Mapping compulsivity in the DSM-5 obsessive compulsive and related disorders: cognitive domains, neural circuitry, and treatment. Int J Neuropsychopharmacol. 2018; 21(1): 42– 58. doi: 10.1093/ijnp/pyx088. 29036632 PMC5795357 · DOI
  37. [46]Haverkampf CJ. Treatment-resistant OCD. J Psychia Psychother Commun. 2014; 30(3): 91– 94.
  38. [47]Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Org. 2004; 82(11): 858– 866. 15640922 PMC2623050
  39. [48]Wootton BM. Remote cognitive-behavior therapy for obsessive–compulsive symptoms: a meta-analysis. Clin Psychol Rev. 2016; 43: 103– 113. doi: 10.1016/j.cpr.2015.10.001. 26494179 · DOI · Paper page
  40. [49]Hollander E, Stein DJ, Kwon JH, et al. Psychosocial function and economic costs of obsessive–compulsive disorder. CNS Spectr. 1997; 2(10): 16– 25. doi: 10.1017/S1092852900011068. · DOI
  41. [50]National Institute for Health and Care Excellence (2005). Obsessive-compulsive disorder and body dysmorphic disorder: treatment. Accessed 24 October 2020. https://www.nice.org.uk/Guidance/CG31 31869034
  42. [54]Abramowitz JS, Franklin ME, Foa EB. Empirical status of cognitive-behavioral therapy for obsessive–compulsive disorder: a meta-analytic review. Romanian J Cogn Behav Psychother. 2002; 2(2): 89– 104.
  43. [56]Kozak MJ. Evaluating treatment efficacy for obsessive–compulsive disorder: caveat practitioner. Cognitive Behav Pract. 1999; 4(6): 422– 426. doi: 10.1016/S1077-7229(99)80061-3. · DOI
  44. [58]Schruers K, Koning K, Luermans J, Haack MJ, Griez E. Obsessive–compulsive disorder: a critical review of therapeutic perspectives. Acta Psychiatr Scand. 2005; 111(4): 261– 271. doi: 10.1111/j.1600-0447.2004.00502.x. 15740462 · DOI
  45. [59]Maltby N, Tolin DF. A brief motivational intervention for treatment‐refusing OCD patients. Cogn Behav Ther. 2005; 34(3): 176– 184. doi: 10.1080/16506070510043741. 16195056 · DOI
  46. [61]Norton PJ, Hayes-Skelton SA, Klenck SC. What happens in session does not stay in session: changes within exposures predict subsequent improvement and dropout. J Anxiety Disord. 2011; 25(5): 654– 660. doi: 10.1016/j.janxdis.2011.02.006. 21419597 PMC3089678 · DOI
  47. [62]O’Neill J, Feusner JD. Cognitive-behavioral therapy for obsessive-compulsive disorder: access to treatment, prediction of long-term outcome with neuroimaging. Psychol Res Behav Manag. 2015; 8: 211– 223. doi: 10.2147/PRBM.S75106. 26229514 PMC4516342 · DOI · Paper page
  48. [63]van der Heiden C, van Rossen K, Dekker A, Damstra M, Deen M. Metacognitive therapy for obsessive-compulsive disorder: a pilot study. J Obsessive-Compulsive Rel Disord. 2016; 9: 24– 29. doi: 10.1016/j.jocrd.2016.02.002. · DOI
  49. [65]Boisseau CL, Schwartzman CM, Lawton J, Mancebo MC. App-guided exposure and response prevention for obsessive compulsive disorder: an open pilot trial. Cogn Behav Ther. 2017; 46(6): 447– 458. doi: 10.1080/16506073.2017.1321683. 28565937 · DOI
  50. [66]Harris P, Drummond L, Fineberg N. Obsessive–compulsive disorder: current management options. Prescriber. 2019; 30(10): 14– 21.
  51. [67]Skapinakis P, Caldwell DM, Hollingworth W, et al. Pharmacological and psychotherapeutic interventions for management of obsessive–compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychia. 2016; 3(8): 730– 739. doi: 10.1016/S2215-0366(16)30069-4. PMC4967667 27318812 · DOI · Paper page
  52. [69]Veale D, Miles S, Smallcombe N, Ghezai H, Goldacre B, Hodsoll J. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychia. 2014; 14: 317. PMC4262998 25432131
  53. [70]Fineberg NA, Stein DJ, Premkumar P, et al. Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive–compulsive disorder: a meta-analysis of randomized controlled treatment trials. Int Clin Psychopharmacol. 2006; 21(6): 337– 343. doi: 10.1097/01.yic.0000215083.57801.11. 17012980 · DOI · Paper page
  54. [71]Alonso P, Cuadras D, Gabriëls L, et al. Deep brain stimulation for obsessive–compulsive disorder: a meta-analysis of treatment outcome and predictors of response. PloS One. 2015; 10(7): e0133591. doi: 10.1371/journal.pone.0133591. 26208305 PMC4514753 · DOI · Paper page
  55. [72]Tyagi H, Apergis-Schoute AM, Akram H, et al. A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive–compulsive disorder: clinical and imaging evidence for dissociable effects. Biol Psychia. 2019; 85(9): 726– 734. doi: 10.1016/j.biopsych.2019.01.017. PMC6467837 30853111 · DOI · Paper page
  56. [73]Dougherty DD, Rauch SL, Jenike MA. Pharmacotherapy for obsessive–compulsive disorder. J Clin Psychol. 2004; 60(11): 1195– 1202. doi: 10.1002/jclp.20083. 15389617 · DOI · Paper page
  57. [74]Fineberg NA, Brown A. Pharmacotherapy for obsessive–compulsive disorder. Adv Psychiatric Treat. 2011; 17(6): 419– 434. doi: 10.1192/apt.bp.109.007237. · DOI
  58. [76]Fama J, Wilhelm S. Formal cognitive therapy: a new treatment for OCD In: Abramowitz JS, Houts AC, eds. Concepts and Controversies in Obsessive–Compulsive Disorder. New York, NY: Springer; 2005: 263– 281.
  59. [80]Vogel PA, Solem S, Hagen K, et al. A pilot randomized controlled trial of videoconference-assisted treatment for obsessive–compulsive disorder. Behav Res Ther. 2014; 63: 162– 168. doi: 10.1016/j.brat.2014.10.007. 25461792 · DOI · Paper page
  60. [81]Lovell K, Cox D, Haddock G, et al. Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial. British Med J. 2006; 333(7574): 883. doi: 10.1136/bmj.38940.355602.80. PMC1626332 16935946 · DOI · Paper page
  61. [83]Insel TR, Voon V, Nye JS, et al. Innovative solutions to novel drug development in mental health. Neurosci Biobehav Rev. 2013; 37(10): 2438– 2444. doi: 10.1016/j.neubiorev.2013.03.022. 23563062 PMC3788850 · DOI · Paper page
  62. [84]Jalal B, Brühl A, O’Callaghan C, et al. Novel smartphone interventions improve cognitive flexibility and obsessive–compulsive disorder symptoms in individuals with contamination fears. Sci Rep. 2018; 8(1): 14923. doi: 10.1038/s41598-018-33142-2. 30353111 PMC6199277 · DOI
  63. [87]Perna G, Grassi M, Caldirola D, Nemeroff CB. The revolution of personalized psychiatry: will technology make it happen sooner? Psychol Med. 2018; 48(5): 705– 713. doi: 10.1017/S0033291717002859. 28967349 · DOI
  64. [91]Whiteside SP, Ale CM, Vickers Douglas K, Tiede MS, Dammann JE. Case examples of enhancing pediatric OCD treatment with a smartphone application. Clin Case Stud. 2014; 13(1): 80– 94. doi: 10.1177/1534650113504822. · DOI
  65. [92]Whiteside SP, Biggs BK, Tiede MS, et al. An online- and mobile-based application to facilitate exposure for childhood anxiety disorders. Cogn Behav Pract. 2019; 26(3): 478– 491. doi: 10.1016/j.cbpra.2019.01.002. PMC8023388 33828399 · DOI
  66. [93]Gershkovich M, Middleton R, Hezel DM, et al. Integrating exposure and response prevention with a mobile app to treat obsessive–compulsive disorder: feasibility, acceptability, and preliminary effects. Behav Ther. 2020 10.1016/j.beth.2020.05.001 33622508 · DOI
  67. [94]Roncero M, Belloch A, Doron G. A novel approach to challenging OCD related beliefs using a mobile-app: an exploratory study. J Behav Ther Exp Psychia. 2018; 59: 157– 160. doi: 10.1016/j.jbtep.2018.01.008. 29425951 · DOI
  68. [95]Roncero M, Belloch A, Doron G. Can brief, daily training using a Mobile app help change maladaptive beliefs? Crossover randomized controlled trial. JMIR mHealth uHealth. 2019; 7(2): e11443. doi: 10.2196/11443. 30758294 PMC6391643 · DOI
  69. [96]Jalal B, Ramachandran VS. “I feel your disgust and relief”: can the action understanding system (mirror neuron system) be recruited to induce disgust and relief from contamination vicariously, in individuals with obsessive-compulsive disorder symptoms? Neurocase. 2017; 23(1): 31– 35. doi: 10.1080/13554794.2017.1279638. 28165861 · DOI
  70. [97]Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive–compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008; 32(3): 525– 549. doi: 10.1016/j.neubiorev.2007.09.005. 18061263 PMC2889493 · DOI · Paper page
  71. [98]Levy HC, Radomsky AS. Safety behaviour enhances the acceptability of exposure. Cogn Behav Ther. 2014; 43(1): 83– 92. doi: 10.1080/16506073.2013.819376. 24299223 · DOI
  72. [99]Rachman S, Shafran R, Radomsky AS, Zysk E. Reducing contamination by exposure plus safety behaviour. J Behav Ther Exp Psychia. 2011; 42(3): 397– 404. doi: 10.1016/j.jbtep.2011.02.010. 21458404 · DOI
  73. [100]van den Hout MA, Engelhard IM, Toffolo MBJ, van Uijen SL. Exposure plus response prevention versus exposure plus safety behaviours in reducing feelings of contamination, fear, danger and disgust. An extended replication of Rachman, Shafran, Radomsky & Zysk (2011). J Behav Ther Exp Psychia. 2011; 42(3): 364– 370. doi: 10.1016/j.jbtep.2011.02.009. 21435332 · DOI
  74. [101]Levy HC, Radomsky AS. Are all safety behaviours created equal? A comparison of novel and routinely used safety behaviours in obsessive-compulsive disorder. Cogn Behav Ther. 2016; 45(5): 367– 379. doi: 10.1080/16506073.2016.1184712. 27243978 · DOI
  75. [102]Rachman S, Radomsky AS, Shafran R. Safety behaviour: a reconsideration. Behav Res Ther. 2008; 46(2): 163– 173. doi: 10.1016/j.brat.2007.11.008. 18199423 · DOI
  76. [103]Butcher JN, Mineka S, Hooley JM. Abnormal psychology: Core concepts. Boston, MA: Pearson/Allyn and Bacon; 2008.
  77. [105]Banerjee D. The other side of COVID-19: impact on obsessive compulsive disorder (OCD) and hoarding. Psychia Res. 2020; 288: 112966. doi: 10.1016/j.psychres.2020.112966. PMC7151248 32334276 · DOI
  78. [106]Kumar A, Somani A. Dealing with Corona virus anxiety and OCD. Asian J Psychia. 2020; 51: 102053. doi: 10.1016/j.ajp.2020.102053. PMC7151537 32302962 · DOI
  79. [107]Davide P, Andrea P, Martina O, Andrea E, Davide D, Mario A. The impact of the COVID-19 pandemic on patients with OCD: effects of contamination symptoms and remission state before the quarantine in a preliminary naturalistic study. Psychia Res. 2020; 291: 113213. doi: 10.1016/j.psychres.2020.113213. PMC7280119 32535508 · DOI
  80. [108]Schwabe L, Wolf OT. Stress-induced modulation of instrumental behavior: from goal-directed to habitual control of action. Behav Brain Res. 2011; 219(2): 321– 328. doi: 10.1016/j.bbr.2010.12.038. 21219935 · DOI
  81. [109]Apergis-Schoute AM, Gillan CM, Fineberg NA, et al. Neural basis of impaired safety signaling in obsessive compulsive disorder. Proc Nat Acad Sci. 2017; 114(12): 3216– 3221. doi: 10.1073/pnas.1609194114;. 28265059 PMC5373407 · DOI · Paper page
  82. [110]Fineberg NA, Van Ameringen M, Drummond L, et al. How to manage obsessive-compulsive disorder (OCD) under COVID-19: a clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive Research Network (OCRN) of the European College of Neuropsychopharmacology. Comprehen Psychiatry. 2020; 100: 152– 174. PMC7152877 32388123
  83. [113]Holmes EA, O'Connor RC, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychia. 2020; 7(6): 547– 560. PMC7159850 32304649
  84. [115]Skoog G, Skoog I. A 40-year follow-up of patients with obsessive–compulsive disorder. Arch Gen Psychia. 1999; 56(2): 121– 127. doi: 10.1001/archpsyc.56.2.121. 10025435 · DOI
  85. [116]Dell’Osso B, Buoli M, Hollander E, Altamura AC. Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder. World J Biological Psychia. 2010; 11(1): 59– 65. doi: 10.3109/15622970903418544. 20001657 · DOI

Cited by

Sorted by citations

Authors
Jalal, B., Chamberlain, S. R., Robbins, T. W., & Sahakian, B. J.
Affiliations
University of Cambridge (GB)
Corresponding author
Jalal, Baland
ORCID
Venue
CNS Spectrums
Publisher
Cambridge University Press (CUP)
Published
2020-10-21
Volume
27
Issue
2
Pages
136-144
ISSN
  • 1092-8529 (ISSN-L)
  • 2165-6509
DOI
10.1017/s1092852920001947
PMC
PMC7691644
OpenAlex
W3094398906
Cited by
24
References
29
Citations by year
2026: 1 · 2025: 2 · 2024: 8 · 2023: 6 · 2022: 4 · 2021: 3
FWCI
0.25
Type
journal article
Language
en
Open access
Licence
Locations
  • CNS Spectrums (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • Wellcome Trust (110,049/Z/15/Z, 104631/Z/14/Z)
  • National Institute for Health and Care Research
  • NIHR Cambridge Biomedical Research Centre
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
obsessive-compulsive disorder, fear of contamination, digital mental health interventions, global mental health, COVID-19 pandemic, rural mental health
MeSH terms
Smartphone, COVID-19, Fear, Humans, Mental Health, Obsessive-Compulsive Disorder, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review